Square Pharmaceuticals PLC

1
DHA:SQURPHARMA (Bangladesh)  
BDT 212.20 (-0.38%) May 9
9.29
P/B:
1.54
Market Cap:
BDT 188.10B ($ 1.61B)
Enterprise V:
BDT 142.16B ($ 1.22B)
Volume:
110.58K
Avg Vol (2M):
245.26K
Volume:
110.58K
Avg Vol (2M):
245.26K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Square Pharmaceuticals PLC ( ) from 1990 to May 12 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Square Pharmaceuticals PLC stock (DHA:SQURPHARMA) PE ratio as of May 12 2024 is 9.29. More Details

Square Pharmaceuticals PLC (DHA:SQURPHARMA) PE Ratio (TTM) Chart

To

Square Pharmaceuticals PLC (DHA:SQURPHARMA) PE Ratio (TTM) Historical Data

Total 1249
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Square Pharmaceuticals PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-12 9.3 2024-03-10 9.7
2024-05-09 9.3 2024-03-07 9.7
2024-05-08 9.3 2024-03-06 9.8
2024-05-07 9.3 2024-03-05 9.7
2024-05-06 9.3 2024-03-04 9.7
2024-05-05 9.3 2024-03-03 9.7
2024-05-02 9.2 2024-02-29 9.8
2024-05-01 9.2 2024-02-28 9.8
2024-04-30 9.2 2024-02-27 9.8
2024-04-29 9.1 2024-02-26 9.9
2024-04-28 9.2 2024-02-25 9.9
2024-04-25 9.3 2024-02-22 10.0
2024-04-24 9.3 2024-02-21 9.9
2024-04-23 9.3 2024-02-20 9.9
2024-04-22 9.3 2024-02-19 9.9
2024-04-21 9.3 2024-02-18 9.8
2024-04-18 9.4 2024-02-15 9.9
2024-04-17 9.4 2024-02-14 10.0
2024-04-16 9.4 2024-02-13 9.9
2024-04-15 9.5 2024-02-12 9.9
2024-04-14 9.5 2024-02-11 9.9
2024-04-11 9.5 2024-02-08 9.8
2024-04-10 9.5 2024-02-07 9.8
2024-04-09 9.5 2024-02-06 9.8
2024-04-08 9.6 2024-02-05 9.9
2024-04-07 9.5 2024-02-04 9.9
2024-04-04 9.5 2024-02-01 9.9
2024-04-03 9.5 2024-01-31 9.9
2024-04-02 9.5 2024-01-30 9.9
2024-04-01 9.6 2024-01-29 9.8
2024-03-31 9.5 2024-01-28 9.7
2024-03-28 9.5 2024-01-25 9.9
2024-03-27 9.8 2024-01-24 10.0
2024-03-26 9.8 2024-01-23 10.0
2024-03-25 9.8 2024-01-22 9.8
2024-03-24 9.8 2024-01-21 9.7
2024-03-21 9.8 2024-01-18 9.6
2024-03-20 9.8 2024-01-17 9.6
2024-03-19 9.8 2024-01-16 9.6
2024-03-18 9.8 2024-01-15 9.5
2024-03-17 9.8 2024-01-14 9.5
2024-03-14 9.8 2024-01-11 9.6
2024-03-13 9.7 2024-01-10 9.5
2024-03-12 9.8 2024-01-09 9.5
2024-03-11 9.7 2024-01-08 9.5

Square Pharmaceuticals PLC (DHA:SQURPHARMA) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. The company operates in Bangladesh and sells its products locally and internationally. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs.